溴隐停治疗中枢性高热临床观察

Observation of the treatment of central high fever with Ergolactin

目的:观察溴隐停治疗中枢性高热的效果.方法:将脑血管意外、重度颅脑损伤、脑肿瘤术后等中枢神经疾病引起的中枢性高热患者55例,随机分成二组,即对照组和治疗组,二组均采用物理降温配合治疗.其中,对照组27例,同时给予解热镇痛剂对乙酰氨基酚;治疗组28例同时给予溴隐停.每日3次口服,疗程5～7d.结果:治疗组的显效率25%,总有效率85.7%;对照组显效率7.4%,总有效率53.5%,治疗组显效率和总有效率均高于对照组.结论:溴隐停治疗中枢性高热疗效显著.

Objective To explore the effect of decreasing the body temperature of patients with high fever by Ergolactin. Method A total of 55 cases of cerebral accidents, craniocerebral injuries and post-operative brain tumor with central high fever were randomly allocated to two groups: treatment group(n=28), control group (n=27). The two groups were treated to decrease the body temperature with physical means. Meanwhile control group received Paracetamol and the treatment group received Ergolactin. Results The remarkable positive effective rate of treatment group is 25% and the total effective rate is 85.7%, compared to the 7.4% and 53.5% of control group. The effect of treatment group is higher than control group obviously. Conclusion Ergolactin has a significant effect in the treatment of central high fever.